While selling off its three power brands – Strepsils, Clearasil and Nurofen, seems illogical, the fact is that Boots has got a spectacular price for its sell-off, and that proves the timing for sale was excellent. While investors welcome the special dividend, Boots must now leverage its Alliance tie-up to enhance its retail strength in Europe. Definitely a time to make the buck roll.
For More IIPM Editorial Article, Click here
For More IIPM Editorial Article, Click here
Source: IIPM Editorial, 2006
